Novartis fights Roche in $210 mln U.S. dispute over licensing fees
ZURICH, June 29 (Reuters) - Novartis wants Roche to return $210 million after accusing its Swiss rival of inappropriately pocketing fees from a 16-year-old...
ZURICH, June 29 (Reuters) - Novartis wants Roche to return $210 million after accusing its Swiss rival of inappropriately pocketing fees from a 16-year-old...